Immunotherapeutic formulations with Interleukin-2-neutralising capacity

Details for Australian Patent Application No. 2005306186 (hide)

Owner Centro De Inmunologia Molecular

Inventors Alonso Sarduy, Livan Bladimir; Lage Davila, Agustin Bienvenido; Perez Rodriguez, Rolando; Montero Casimiro, Jose Enrique

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005306186

PCT Pub. Number WO2006/053508

Priority 261-2004 16.11.04 CU

Filing date 16 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 31 May 2012

International Classifications

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/053508 Priority application(s): WO2006/053508

16 August 2007 Change of Name(s) of Applicant(s), Section 104

  Centro De Inmunolgia Molecular The name of the applicant has been changed to Centro De Inmunologia Molecular

31 May 2012 Application Accepted

  Published as AU-B-2005306186

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306192-Process for monitoring territories in order to recognise forest and surface fires

2005306168-TNF antagonists